drugset / Trial / NCT02397863
Epidiolex and Drug Resistant Epilepsy in Children
Summary
This open-label, multi-center study is open to patients 1 to 18 years of age at time of enrollment with medication resistant epilepsy.
Timeline
- Start
- 2014-12
- Primary completion
- 2019-12
- Completion
- 2020-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 25 mg/kg | — |
| Subject | Cannabidiol | Other / unclassified | 50 mg/kg | — |